TP53 and myelodysplastic syndrome: Furthermore, the outcome prediction model of OS proposed by Heuser and colleagues for MDS and sAML/MDS after allo‐HCT incorporated nine variables, five of these are disease‐related genetic changes including mutated NRAS, U2AF1, IDH2, TP53, and/or a complex karyotype [8].